Alignment Healthcare, Inc.
ALHCNasdaqCIK 1832466FinancialsFiscal year ends Dec 31
Reports and events: 88 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2916:15 ET | 10-Q | Quarterly reportPeriod 2026-09-30 | 0001628280-26-068247 |
| 2026-10-2916:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-006971 |
| 2026-10-0817:13 ET | 8-K | 7.01 Regulation FD disclosure | 0001628280-26-065470 |
| 2026-07-3016:14 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001628280-26-051060 |
| 2026-07-3016:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-005078 |
| 2026-06-0916:31 ET | 8-K | 5.07 Shareholder vote results | 0001628280-26-041926 |
| 2026-05-1216:33 ET | 8-K | 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure | 0001628280-26-034147 |
| 2026-04-3016:14 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001628280-26-028901 |
| 2026-04-3016:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-002895 |
| 2026-04-2410:52 ET | DEF 14A | Proxy statementPeriod 2026-06-04 | 0001628280-26-027058 |
| 2026-03-0416:08 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-091486 |
| 2026-02-2721:18 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001628280-26-012545 |
| 2026-02-2616:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-001139 |
| 2026-01-1209:10 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-001783 |
| 2025-10-3016:11 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001628280-25-047538 |
| 2025-10-3016:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-006831 |
| 2025-09-0917:03 ET | 8-K | 7.01 Regulation FD disclosure | 0001832466-25-000006 |
| 2025-07-3016:11 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001628280-25-036713 |
| 2025-07-3016:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-004825 |
| 2025-06-1117:06 ET | 8-K | 5.07 Shareholder vote results | 0001628280-25-030795 |
| 2025-05-0116:30 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001628280-25-021571 |
| 2025-05-0116:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-002689 |
| 2025-04-2516:17 ET | DEF 14A | Proxy statementPeriod 2025-06-05 | 0001628280-25-019952 |
| 2025-04-1516:38 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001628280-25-017872 |
| 2025-04-1116:45 ET | 8-K | 8.01 Other events | 0001628280-25-017553 |
| 2025-02-2716:50 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001628280-25-008730 |
| 2025-02-2716:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-001127 |
| 2025-01-1308:44 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-001253 |
| 2024-11-2516:44 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001628280-24-049159 |
| 2024-11-1506:50 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-048032 |
| 2024-10-2916:04 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001628280-24-044092 |
| 2024-10-2916:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-24-005854 |
| 2024-08-1616:43 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-24-037577 |
| 2024-08-0116:04 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001628280-24-034114 |
| 2024-08-0116:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-24-004355 |
| 2024-06-1417:18 ET | 8-K | 2.03 New direct financial obligation | 0001628280-24-028334 |
| 2024-06-1317:42 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001628280-24-027889 |
| 2024-06-0616:59 ET | 8-K | 8.01 Other events | 0001628280-24-027112 |
| 2024-05-0216:06 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001628280-24-019994 |
| 2024-05-0216:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-24-002487 |
| 2024-04-2609:02 ET | DEF 14A | Proxy statementPeriod 2024-06-07 | 0001193125-24-116055 |
| 2024-02-2716:14 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-021154 |
| 2024-02-2716:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-24-001014 |
| 2024-01-0808:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-002706 |
| 2023-12-2917:07 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-23-073907 |
| 2023-11-0216:11 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-23-058207 |
| 2023-11-0216:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-23-006669 |
| 2023-09-1517:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-23-048416 |
| 2023-09-0616:46 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-23-046764 |
| 2023-08-1516:37 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-23-042834 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 18:01 ET. Listed shows no prices and gives no investment advice.